-
1
المؤلفون: Jean-Luc Van Laethem, Séverine Racadot, Pascal Hammel, Dewi Vernerey, Florence Huguet, Paul Van Houtte, Bengt Glimelius, David Goldstein, Nigel Spry, Paul Giraud, Michael Gubanski
المصدر: International Journal of Radiation Oncology*Biology*Physics. 110:993-1002
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Nausea, medicine.medical_treatment, 030218 nuclear medicine & medical imaging, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Chemotherapy, Radiation, business.industry, Hazard ratio, Induction chemotherapy, Chemoradiotherapy, Middle Aged, Progression-Free Survival, Confidence interval, Pancreatic Neoplasms, Radiation therapy, Oncology, 030220 oncology & carcinogenesis, Female, medicine.symptom, business
-
2
المؤلفون: Benjamin Lacas, Alexandra Carmel, Cécile Landais, Stuart J. Wong, Lisa Licitra, Jeffrey S. Tobias, Barbara Burtness, Maria Grazia Ghi, Ezra E.W. Cohen, Cai Grau, Gregory Wolf, Ricardo Hitt, Renzo Corvò, Volker Budach, Shaleen Kumar, Sarbani Ghosh Laskar, Jean-Jacques Mazeron, Lai-Ping Zhong, Werner Dobrowsky, Pirus Ghadjar, Carlo Fallai, Branko Zakotnik, Atul Sharma, René-Jean Bensadoun, Maria Grazia Ruo Redda, Séverine Racadot, George Fountzilas, David Brizel, Paolo Rovea, Athanassios Argiris, Zoltán Takácsi Nagy, Ju-Whei Lee, Catherine Fortpied, Jonathan Harris, Jean Bourhis, Anne Aupérin, Pierre Blanchard, Jean-Pierre Pignon, D.J. Adelstein, M. Alfonsi, Y. Belkacemi, V. Bar-Ad, J. Bernier, Å. Bratland, G. Calais, B. Campbell, J. Caudell, S. Chabaud, E. Chamorey, D. Chaukar, K.N. Choi, O. Choussy, L. Collette, J.J. Cruz, C. Dani, E. Dauzier, A.A. Forastiere, P. Garaud, V. Gregoire, A. Hackshaw, E. Haddad, B.G. Haffty, A. Hansen, S. Hayoz, J.C. Horiot, B. Jeremic, T.G. Karrison, J.A. Langendijk, M. Lapeyre, E. Lartigau, T. Leong, Q.T. Le, P.P.Y. Lee, F. Lewin, A. Lin, A. Lopes, S. Mehta, J. Moon, E. Moyal, B.V. Occéan, P. Olmi, R. Orecchia, B. O'Sullivan, J. Overgaard, C. Petit, H. Quon, G. Sanguineti, T. Satar, J. Simes, C. Simon, C. Sire, S. Staar, C. Stromberger, P. Strojan, S. Temam, D. Thomson, A. Timochenko, V. Torri, V. Tseroni, J. Vermorken, E.E. Vokes, J. Waldron, K.D. Wernecke, J. Widder, B. Zackrisson
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)
المصدر: MACH-NC Collaborative Group 2021, ' Meta-analysis of chemotherapy in head and neck cancer (MACH-NC) : An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group ', Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology . https://doi.org/10.1016/j.radonc.2021.01.013
Radiother Oncol
Lacas, B, Carmel, A, Landais, C, Wong, S J, Licitra, L, Tobias, J S, Burtness, B, Ghi, M G, Cohen, E E W, Grau, C, Wolf, G, Hitt, R, Corvò, R, Budach, V, Kumar, S, Laskar, S G, Mazeron, J J, Zhong, L P, Dobrowsky, W, Ghadjar, P, Fallai, C, Zakotnik, B, Sharma, A, Bensadoun, R J, Ruo Redda, M G, Racadot, S, Fountzilas, G, Brizel, D, Rovea, P, Argiris, A, Nagy, Z T, Lee, J W, Fortpied, C, Harris, J, Bourhis, J, Aupérin, A, Blanchard, P, Pignon, J P & MACH-NC Collaborative Group 2021, ' Meta-analysis of chemotherapy in head and neck cancer (MACH-NC) : An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group ', Radiotherapy and Oncology, vol. 156, pp. 281-293 . https://doi.org/10.1016/j.radonc.2021.01.013
Radiotherapy and Oncology, 156, 281-293. ELSEVIER IRELAND LTDمصطلحات موضوعية: Oncology, medicine.medical_treatment, Review, 030218 nuclear medicine & medical imaging, law.invention, 0302 clinical medicine, Randomized controlled trial, Carcinoma, Squamous Cell/drug therapy, law, Antineoplastic Combined Chemotherapy Protocols, Stage (cooking), Adjuvant, Cancer, Randomized Controlled Trials as Topic, PHASE-III TRIAL, Induction Chemotherapy, Hematology, Head and Neck Cancer, 6.5 Radiotherapy and other non-invasive therapies, Other Physical Sciences, Head and Neck Neoplasms/therapy, Chemotherapy, Adjuvant, Head and Neck Neoplasms, Randomised Clinical Trials, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, SQUAMOUS-CELL CARCINOMA, LOCALLY ADVANCED HEAD, Chemotherapy, Individual Patient Data, Meta-analysis, Radiotherapy, medicine.medical_specialty, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, MITOMYCIN-C, ADVANCED RESECTABLE HEAD, Article, 03 medical and health sciences, Rare Diseases, Clinical Research, RADIATION-THERAPY, Internal medicine, CONCURRENT CHEMORADIOTHERAPY, medicine, Carcinoma, Humans, Radiology, Nuclear Medicine and imaging, Oncology & Carcinogenesis, Performance status, business.industry, Head and neck cancer, Evaluation of treatments and therapeutic interventions, Induction chemotherapy, medicine.disease, MACH-NC Collaborative Group, Radiation therapy, Squamous Cell, LOCOREGIONALLY ADVANCED-CARCINOMA, Concomitant, INDIVIDUAL PARTICIPANT DATA, business
وصف الملف: application/pdf
-
3
المؤلفون: Xavier Mirabel, Véronique Vendrely, Loig Vaugier, Jean-Luc Raoul, Marc-André Mahé, Christian Carrie, Loïc Campion, Séverine Racadot, Isabelle Martel-Lafay, Hélène Senellart, Emmanuel Rio
المساهمون: Bernardo, Elizabeth, Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Centre Léon Bérard [Lyon], Hôpital Saint-André, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), Université Lille Nord de France (COMUE)-UNICANCER
المصدر: Cancers, Vol 13, Iss 248, p 248 (2021)
Cancers
Cancers, 2021, 13 (2), pp.248. ⟨10.3390/cancers13020248⟩
Cancers, MDPI, 2021, 13 (2), pp.248. ⟨10.3390/cancers13020248⟩
Volume 13
Issue 2مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Colorectal cancer, medicine.medical_treatment, [SDV.CAN]Life Sciences [q-bio]/Cancer, colorectal cancer, Gastroenterology, lcsh:RC254-282, Article, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Quality of life, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, medicine, irinotecan, Response rate (survey), Chemotherapy, Lung, business.industry, lung metastases, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, oligometastases, 3. Good health, Irinotecan, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Concomitant, Radiosensitizing Agent, stereotactic radiotherapy, business, liver metastases, medicine.drug
وصف الملف: application/pdf
-
4
المؤلفون: Brian O'Sullivan, Everett E. Vokes, J. Bernier, J. Vermorken, Jean-Jacques Mazeron, J.W. Lee, J. Simes, Carlo Fallai, P. Olmi, Cai Grau, K.H. Cho, B. Lacas, J.J. Cruz Hernandez, P. Graff-Cailleaud, Branislav Jeremic, J. Overgaard, Giuseppe Sanguineti, J.H. Hay, Voichita Bar-Ad, B. Gery, H. Quon, W. Dobrowsky, B. Maciejewski, M. Nankivell, Catherine Fortpied, Y. Belkacemi, Z. Szutkowski, V. Budach, David J. Adelstein, Maria Grazia Ghi, Allan Hackshaw, A. Trotti, Vincent Grégoire, Jens Overgaard, P. Blanchard, David I. Rosenthal, B. O'Sullivan, B.G. Haffty, Ju-Whei Lee, E. Moyal, M. Alfonsi, O. Choussy, S. Kumar, Barbara Burtness, M. Cheugoua-Zanetsie, C.M.P. Viegas, V. Tseroni, E. Lartigau, H. Bartelink, Björn Zackrisson, Jean-Pierre Pignon, S. Staar, J. Waldron, J.S. Wu, A. Lopes, M.G. Ghi, Sarbani Ghosh Laskar, Lisa Licitra, K.D Wernecke, C. Grau, Y.G. Tao, J. Agarwal, Yoann Pointreau, Maurice Cheugoua-Zanetsie, M. Lotayef, G. Calais, Claire Petit, J. Moon, J.A. Langendijk, C.A. Kristensen, W. Budach, Mahesh K.B. Parmar, Mahesh K. B. Parmar, Athanassios Argiris, Benjamin Lacas, C. Sire, S. Spencer, Beth M. Beadle, C. Petit, John Simes, Michael Poulsen, Arlene A. Forastiere, Q.T. Le, Adam S. Garden, L.P. Zhong, J.J. Mazeron, H. van Tinteren, Å. Bratland, Jean Pierre Pignon, Yi Li, Jeffrey S Tobias, S.H. Moon, P. Strojan, J. Bourhis, S. Temam, A. Bacigalupo, Pedro A. Torres-Saavedra, E.E. Vokes, C.M.L. Driessen, Stéphane Temam, M.M Dominello, E. Chamorey, J. Widder, Ricardo Hitt, C. van Herpen, Séverine Racadot, M. Julieron, H. Yamazaki, Rafał Suwiński, Z. Takácsi-Nagy, A. Hansen, K. Skladowski, D. Chaukar, P. Lee, S. Hayoz, F. Lewin, Marshall R. Posner, Atul Sharma, S. Mehta, M.G. Poulsen, S. Ghosh Laskar, R. Suwinski, B. Campbell, Wojciech Michalski, Jimmy J. Caudell, Jørgen Johansen, C. Simon, C. Fortpied, R. Orecchia, Volker Budach, George Shenouda, V. Torri, Shaleen Kumar, E Haddad, P. Rovea, P. Torres-Saavedra, Juan Jesús Cruz Hernández, Lai-Ping Zhong, Quynh-Thu Le, B. Zaktonik, J.W. Denham, A. Aupérin, B. Zackrisson, Gregory T. Wolf, J.C. Horiot, C. Stromberger, Jean Bourhis, S. Chabaud, Michel Lapeyre, Eric Lartigau, S.J. Wong, George Fountzilas, P. Nilsson, David M. Brizel, M.R. Posner, L. Tripcony, René-Jean Bensadoun, C. Jones, M.G. Ruo Redda, Pierre Blanchard, D. Thomson, A. Hackshaw, B. Jeremic, G. Sanguineti, Pirus Ghadjar, A. Auperin, P. Garaud
المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Lancet Oncology, 22, 727-736
Petit, C, Lacas, B, Pignon, J-P, Le, Q T, Grégoire, V, Grau, C, Hackshaw, A, Zackrisson, B, Parmar, M K B, Lee, J-W, Ghi, M G, Sanguineti, G, Temam, S, Cheugoua-Zanetsie, M, O'Sullivan, B, Posner, M R, Vokes, E E, Cruz Hernandez, J J, Szutkowski, Z, Lartigau, E, Budach, V, Suwiński, R, Poulsen, M, Kumar, S, Ghosh Laskar, S, Mazeron, J-J, Jeremic, B, Simes, J, Zhong, L-P, Overgaard, J, Fortpied, C, Torres-Saavedra, P, Bourhis, J, Aupérin, A, Blanchard, P & MACH-NC and MARCH Collaborative Groups 2021, ' Chemotherapy and radiotherapy in locally advanced head and neck cancer : an individual patient data network meta-analysis ', The Lancet Oncology, vol. 22, no. 5, pp. 727-736 . https://doi.org/10.1016/S1470-2045(21)00076-0
The Lancet Oncology, 22(5), 727-736. ELSEVIER SCIENCE INC
Lancet Oncology, 22, 5, pp. 727-736
Petit, C, Lacas, B, Pignon, J P, Le, Q T, Grégoire, V, Grau, C, Hackshaw, A, Zackrisson, B, Parmar, M K B, Lee, J W, Ghi, M G, Sanguineti, G, Temam, S, Cheugoua-Zanetsie, M, O'Sullivan, B, Posner, M R, Vokes, E E, Cruz Hernandez, J J, Szutkowski, Z, Lartigau, E, Budach, V, Suwiński, R, Poulsen, M, Kumar, S, Ghosh Laskar, S, Mazeron, J J, Jeremic, B, Simes, J, Zhong, L P, Overgaard, J, Fortpied, C, Torres-Saavedra, P, Bourhis, J, Aupérin, A, Blanchard, P, MACH-NC and MARCH Collaborative Groups & Johansen, J 2021, ' Chemotherapy and radiotherapy in locally advanced head and neck cancer : an individual patient data network meta-analysis ', The Lancet Oncology, vol. 22, no. 5, pp. 727-736 . https://doi.org/10.1016/S1470-2045(21)00076-0مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, medicine.medical_treatment, Network Meta-Analysis, Head and Neck Neoplasms/mortality, chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, head and neck cancer, radiotherapy, chemotherapy, radiochemotherapy, 030212 general & internal medicine, radiotherapy, business.industry, Head and neck cancer, Hazard ratio, Dose fractionation, Induction chemotherapy, Cancer, Chemoradiotherapy, medicine.disease, Radiation therapy, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Concomitant, Female, head and neck cancer, radiochemotherapy, Dose Fractionation, Radiation, business, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]
وصف الملف: application/pdf
-
5
المؤلفون: Julian Biau, J. Miroir, Nicolas Saroul, C. Millardet, Michel Lapeyre, J. H. Bourhis, B. Pereira, Florence Huguet, N. Pham-Dang, Fabrice Kwiatkowski, Séverine Racadot
المساهمون: Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Centre Léon Bérard [Lyon], Laboratoire d'Hématologie [Purpan], Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], Cognition et Activités finalisées (CAF), Centre National de la Recherche Scientifique (CNRS)-Université Paris 8 Vincennes-Saint-Denis (UP8), CHU Clermont-Ferrand, Département de Radiothérapie, Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Service de Radiothérapie (CLERMONT FERRAND - Radiothérapie)
المصدر: Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2017, 21 (6-7), pp.527-532. ⟨10.1016/j.canrad.2017.07.033⟩مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, Brachytherapy, Population, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Quality of life, medicine, Radiology, Nuclear Medicine and imaging, Stage (cooking), education, ComputingMilieux_MISCELLANEOUS, Gynecology, Chemotherapy, education.field_of_study, business.industry, Cancer, medicine.disease, 3. Good health, Radiation therapy, Oncology, 030220 oncology & carcinogenesis, Concomitant, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
-
6
المؤلفون: Joël Guigay, F. Elloumi, Pierre Blanchard, Jamel Daoud, Yungan Tao, A. Cornely, P. Lang, S. Sun, N. Toumi, Jean Bourhis, A. Moussa, C. Tuchais, Séverine Racadot, Anne Auperin, Juliette Thariat, Marc Alfonsi, M. Frikha
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 29(3)
مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Urology, Docetaxel, Kaplan-Meier Estimate, 03 medical and health sciences, 0302 clinical medicine, TPF Regimen, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Survival rate, Aged, Cisplatin, Chemotherapy, Nasopharyngeal Carcinoma, business.industry, Nasopharyngeal Neoplasms, Hematology, Chemoradiotherapy, Induction Chemotherapy, Middle Aged, medicine.disease, Chemotherapy regimen, 030104 developmental biology, Oncology, Nasopharyngeal carcinoma, 030220 oncology & carcinogenesis, Concomitant, Female, Fluorouracil, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c370b31cf44a324db7e445c8eca98c91
https://pubmed.ncbi.nlm.nih.gov/29236943 -
7
المؤلفون: Philippe Zrounba, Séverine Racadot, Sylvie Chabaud, Anthony Montella, Thomas Bachelot, Bertrand Favier, Pascal Pommier, D. Girodet, X. Montbarbon, Jérôme Fayette
المصدر: Anti-Cancer Drugs. 21:553-558
مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Paclitaxel, medicine.medical_treatment, Population, Cetuximab, Antibodies, Monoclonal, Humanized, Carboplatin, chemistry.chemical_compound, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Humans, Pharmacology (medical), education, Aged, Retrospective Studies, Aged, 80 and over, Pharmacology, Cisplatin, Chemotherapy, education.field_of_study, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Antineoplastic Agents, Phytogenic, Survival Analysis, Head and neck squamous-cell carcinoma, Treatment Outcome, chemistry, Head and Neck Neoplasms, Carcinoma, Squamous Cell, Neoplasm Recurrence, Local, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31e1890d9e9c33be155622f5a410906
https://doi.org/10.1097/cad.0b013e3283388e60 -
8
المؤلفون: Séverine Racadot, Yann Molin, X. Montbarbon, P. Pommier, Marc Poupart, Philippe Zrounba, Emilie Lavergne, Jérôme Fayette, Philippe Ceruse, Antoine Ramade
المصدر: Drug Design, Development and Therapy
مصطلحات موضوعية: Adult, Male, Oncology, Radiation-Sensitizing Agents, medicine.medical_specialty, medicine.medical_treatment, cisplatin, Pharmaceutical Science, Antineoplastic Agents, Disease-Free Survival, Drug Administration Schedule, Young Adult, Internal medicine, Drug Discovery, medicine, Humans, radiotherapy potentiation, chemoradiation, Survival rate, Aged, Retrospective Studies, Original Research, Pharmacology, Cisplatin, Chemotherapy, Drug Design, Development and Therapy, business.industry, Head and neck cancer, Chemoradiotherapy, Middle Aged, Prognosis, medicine.disease, Head and neck squamous-cell carcinoma, Survival Rate, Radiation therapy, stomatognathic diseases, Head and Neck Neoplasms, Toxicity, Carcinoma, Squamous Cell, Female, head and neck cancer, Neoplasm Recurrence, Local, business, medicine.drug
وصف الملف: text/html
-
9
المؤلفون: Jean-Jacques Mazeron, M. Martin, E. Haddad, Pierre Géhanno, Jocelyne Huet, Catherine Durdux, René-Jean Bensadoun, Séverine Racadot, Christian Diana, G. Calais, Catherine Journel, Michel Henry-Amar, V. Favrel, Brigitte Blaska-Jaulerry, Sophie Dussart, François Baillet, Martin Housset, Christophe Hennequin, Bernadette Dessard-Diana, Gérard Pillet, Mariette Mercier, Emmanuelle Malaurie
المساهمون: Centre Alexis Vautrin ( CAV ), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), Laboratoire Pierre Süe ( LPS ), Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Centre National de la Recherche Scientifique ( CNRS ), Centre Hospitalier Lyon Sud [CHU - HCL] ( CHLS ), Hospices Civils de Lyon ( HCL ), Universite Antonine ( UPA ), Université Antonine, Centre Alexis Vautrin (CAV), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (UR 3181) (CEF2P / CARCINO), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Laboratoire Pierre Süe (LPS), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Université Antonine (UA), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Universite Antonine (UPA)
المصدر: Radiotherapy and Oncology
Radiotherapy and Oncology, Elsevier, 2008, 87 (2), pp.164-172. 〈10.1016/j.radonc.2007.12.021〉
Radiotherapy & Oncology
Radiotherapy & Oncology, 2008, 87 (2), pp.164-172. ⟨10.1016/j.radonc.2007.12.021⟩
Radiotherapy and Oncology, Elsevier, 2008, 87 (2), pp.164-172. ⟨10.1016/j.radonc.2007.12.021⟩مصطلحات موضوعية: Male, MESH: Combined Modality Therapy, MESH: Lymphatic Metastasis, medicine.medical_treatment, MESH: Laryngeal Neoplasms, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, Carboplatin, MESH: Proportional Hazards Models, chemistry.chemical_compound, 0302 clinical medicine, MESH : Oropharyngeal Neoplasms, MESH: Carboplatin, MESH : Female, MESH : Carcinoma, Squamous Cell, Neoplasm Metastasis, MESH: Radiotherapy Dosage, 030223 otorhinolaryngology, Lymph node, MESH: Treatment Outcome, MESH : Laryngeal Neoplasms, education.field_of_study, MESH: Middle Aged, MESH : Radiotherapy Dosage, Hazard ratio, MESH: Carcinoma, Squamous Cell, MESH : Lymphatic Metastasis, Radiotherapy Dosage, Hematology, Middle Aged, MESH : Survival Rate, Combined Modality Therapy, 3. Good health, Survival Rate, MESH : Antineoplastic Agents, Oropharyngeal Neoplasms, medicine.anatomical_structure, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, MESH : Carboplatin, Lymphatic Metastasis, MESH : Neoplasm Metastasis, Carcinoma, Squamous Cell, Female, medicine.medical_specialty, MESH: Survival Rate, MESH : Male, Population, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antineoplastic Agents, MESH : Treatment Outcome, 03 medical and health sciences, medicine, Humans, Radiology, Nuclear Medicine and imaging, MESH : Middle Aged, education, Survival rate, Laryngeal Neoplasms, Proportional Hazards Models, Chemotherapy, MESH: Humans, business.industry, MESH : Humans, MESH : Proportional Hazards Models, MESH: Neoplasm Metastasis, MESH: Male, Surgery, Radiation therapy, MESH: Oropharyngeal Neoplasms, chemistry, Concomitant, MESH: Antineoplastic Agents, business, MESH : Combined Modality Therapy, MESH: Female
-
10
المؤلفون: Pascal Pommier, Philippe Ceruse, Jérôme Fayette, Marc Poupart, Séverine Racadot, Philippe Zrounba, X. Montbarbon, Emilie Lavergne, Yann Molin
المصدر: Journal of Clinical Oncology. 31:6056-6056
مصطلحات موضوعية: Cisplatin, Larynx, Cancer Research, Chemotherapy, business.industry, Proportional hazards model, medicine.medical_treatment, medicine.disease, Head and neck squamous-cell carcinoma, Radiation therapy, medicine.anatomical_structure, Oncology, Toxicity, Medicine, Population study, business, Nuclear medicine, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::97948c59c7c2c87ba9e0eeb741b2d601
https://doi.org/10.1200/jco.2013.31.15_suppl.6056
إعادة تعيين المنقحات
عرض المنقحات (%%عد%%)
Full Text via ClinicalKey 
PDF full text from Publisher